X0306 4 2021-04-07 0001566895 NCINO, INC. NCNO 0001814457 Glover Joshua L 6770 PARKER FARM DRIVE, SUITE 200 WILMINGTON NC 28405 true Chief Revenue Officer Common Stock 2021-04-07 4 M 0 20000 4.98 A 128675 D Common Stock 2021-04-07 4 S 0 9400 70.8101 D 119275 D Common Stock 2021-04-07 4 S 0 6800 71.8429 D 112475 D Common Stock 2021-04-07 4 S 0 3800 72.5825 D 108675 D Stock Option (Right to Buy) 4.98 2021-04-07 4 M 0 20000 0 D 2027-02-01 Common Stock 20000 152058 D The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $70.33 to $71.305, inclusive. The reporting person undertakes to provide to nCino, Inc., any security holder of nCino, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $71.35 to $72.29, inclusive. The reporting person undertakes to provide to nCino, Inc., any security holder of nCino, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $72.35 to $72.785, inclusive. The reporting person undertakes to provide to nCino, Inc., any security holder of nCino, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). This option vests in four equal annual installments starting on February 1, 2018, subject to the reporting person's continued employment through the applicable vesting date. This option fully vests and becomes exercisable upon a change in control of the Issuer. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. /s/ Jeanette Sellers, Attorney-in-Fact for Joshua L. Glover 2021-04-08